These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 18097148

  • 1. Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
    Ishimura E, Okuno S, Taniwaki H, Kizu A, Tsuchida T, Shioi A, Shoji T, Tabata T, Inaba M, Nishizawa Y.
    Kidney Blood Press Res; 2008; 31(1):10-5. PubMed ID: 18097148
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis].
    Nitta K.
    Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
    Ishimura E, Okuno S, Kitatani K, Kim M, Shoji T, Nakatani T, Inaba M, Nishizawa Y.
    Diabetologia; 2002 Oct; 45(10):1446-8. PubMed ID: 12378387
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Vascular calcification in patients with end-stage renal disease.
    Floege J, Ketteler M.
    Nephrol Dial Transplant; 2004 Aug; 19 Suppl 5():V59-66. PubMed ID: 15284362
    [Abstract] [Full Text] [Related]

  • 10. Vascular calcification and disordered mineral metabolism in dialysis patients.
    Kalpakian MA, Mehrotra R.
    Semin Dial; 2007 Aug; 20(2):139-43. PubMed ID: 17374088
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N, Kes P.
    Acta Med Croatica; 2004 Aug; 58(3):207-13. PubMed ID: 15503684
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The antioxidant tempol ameliorates arterial medial calcification in uremic rats: important role of oxidative stress in the pathogenesis of vascular calcification in chronic kidney disease.
    Yamada S, Taniguchi M, Tokumoto M, Toyonaga J, Fujisaki K, Suehiro T, Noguchi H, Iida M, Tsuruya K, Kitazono T.
    J Bone Miner Res; 2012 Feb; 27(2):474-85. PubMed ID: 21987400
    [Abstract] [Full Text] [Related]

  • 17. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K, Tyralla K, Gross ML, Eifert T, Adamczak M, Ritz E.
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular calcification in patients with end-stage renal disease.
    Pecovnik-Balon B.
    Ther Apher Dial; 2005 Jun; 9(3):208-10. PubMed ID: 15966990
    [Abstract] [Full Text] [Related]

  • 20. Osteogenic regulation of vascular calcification: an early perspective.
    Vattikuti R, Towler DA.
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E686-96. PubMed ID: 15102615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.